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Introduction
In recent years, whole genome analysis has become
routine and systems biology and modelling of
whole cells are becoming more common. Advances
in experimental technology now permit expression
analysis for tens of thousands of genes at a time,
generating vast amounts of biological data, and
the application of high-throughput technologies to
proteomics makes the burden even heavier.
Databases and tools have become available to
help biologists manage and interpret these large
volumes of data, but databases alone are not
sufficient to allow researchers to integrate large
amounts, and different kinds, of information. The
problem is that any given biological phenomenon
can be described in many different ways; an exam-
ple is the use of free text annotation in databases
such as GenBank, which has resulted in inconsis-
tent data representation [2]. One promising solution
is to provide consistent annotation within databases
by means of standard formats and ontologies. Stan-
dards development depends on the availability of
suitable ontologies; both the MIAME standard
and emerging proteomics standards recommend the
use of ontologies wherever possible. Where such
ontologies do not exist, communities are starting
to build their own to support standards [5].
Although the exact meaning of the word ‘ontol-
ogy’ is contentious, T.Gruber’s definition of an
ontology as a ‘specification of a conceptualiza-
tion’ (http://www-ksl.stanford.edu/kst/what-is-
an-ontology.html) is widely used. Ontologies are,
at a minimum, sets of terms used in a spe-
cific domain, definitions for those terms and
defined relationships between the terms; they can
range from simple controlled vocabularies to struc-
turally complex representations employing descrip-
tion logics [4]. In biology, the use of ontologies
allows database annotation to be standardized, and
makes sophisticated queries possible for humans
and computers. The SOFG conference brought
together about 120 biological domain experts, com-
puter scientists and those with interests in related
fields, such as natural language processing (NLP),
to address the issues of developing, implementing
and ultimately unifying ontologies. Presentations
covered specific ontologies being developed for a
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wide range of biological domains as well as tools
for constructing ontologies and ways that ontolo-
gies are being put to use in various databases.
It should be noted that ontologies are frequently
developed for use in a database context, and do
not exist in a vacuum.
In the context of this review, we evaluate ontolo-
gies on their content and potential use to biologists,
rather than on the basis of construction methods.
One insight that quickly emerged is that a research
community must be actively involved in develop-
ing and deploying any ontology or standard for
its field, to ensure that the ontology is relevant
and usable. The emergence of the Gene Ontol-
ogy (GO) vocabularies [6,7] as a de facto standard
for gene product annotation illustrates the value of
involving biologists in all stages of the develop-
ment and application of an ontology. Numerous
model organism databases (MGI, FlyBase, SGD,
TAIR, WormBase and others), as well as SWISS-
PROT and LocusLink, provide GO annotations for
their database objects. These groups adopted GO
voluntarily and now make active contributions to
its development. The benefits of widespread com-
munity use of the GO extend beyond the model
organism databases that generate it. Use of GO
facilitates sequence annotation and speeds up the
analysis of large-scale functional genomics exper-
iments, and an increasing number of applications
make use of GO terms and gene product annota-
tions, e.g. several applications combine GO annota-
tions with microarray data to address queries such
as, ‘Which GO terms are over-represented in a
given cluster?’
We can go further in the use of ontologies
than simply annotating gene products to the GO.
Consider the following example: ‘a species X ,
of developmental stage Y , has been treated with
compound Z ’ and the resulting data matrix stored
in a database. If the data alone are stored with
just a free text description, query capability is
limited. In contrast, if ontologies are used to
describe the species, compound and developmental
stage, structured queries, such as ‘what experiments
use compound Y ?’ are possible, as compound
Y is described only once within the database,
and the source ontology provides an unambiguous
definition for Y . This is precisely the type of query
that the standard for microarray data, minimum
information about a microarray (MIAME), was
developed to answer [1].
Keynote presentations
Lincoln Stein (Cold Spring Harbor Laboratory,
USA) speculated on a seemingly universal human
urge to collect and classify objects, a tendency
that finds expression in classification systems for
biology, and which mirrors the urge of children
to collect, classify and describe Pokemon charac-
ters. He provided some insights into the sociology
of naming things, a right that all scientists believe
that they have. Using pathology as an example, he
illustrated how classification systems require revi-
sion because they are often technology-based, and
as technology changes, so the resolving possibili-
ties of the system change.
Winston Hide’s (SANBI, South Africa) key-
note presentation used a population genetics meta-
phor to describe the spread of bioinformatics tech-
nology through the developing world, beginning
in South Africa and extending to other parts of
Africa and South America. Hide emphasized the
point that open source software was, and is, essen-
tial to the development of infrastructure for open
health care in much of the world, before going on
to describe his group’s efforts to provide an open
controlled vocabulary, known as eVOC, for con-
sistently describing clone, EST and cDNA libraries
used in high-throughput experiments.
Ken Buetow (National Cancer Institute, USA)
provided an overview of the National Cancer Insti-
tute’s efforts to unify data related to cancer com-
ing from sources as diverse as epidemiology, clin-
ical trials, cancer animal models and microar-
ray data into a unified system, with ontologies
mapped across these domains into a common onto-
logical representation environment called caCORE
(http://ncicb.nci.nih.gov/NCICB/core). The goal
of these efforts is to support all those involved in
cancer research and facilitate in silico research. The
NCI has not limited itself to a single technology,
providing access to its data via Java, SOAP, XML
and other formats and protocols, thereby placing
itself at the cutting edge of data provision for can-
cer research.
Peter Karp (SRI International, USA) described
various aspects of the BioCyc family of databases
(http://www.biocyc.org/). Each database provides
a knowledge base about a particular organism and
covers several biological datatypes, such as genes,
enzymes and metabolic pathways. Karp also sum-
marized the features of the Pathway Tools software
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used to build and maintain the BioCyc databases
and the underlying ontologies used.
Michael Ashburner [European Bioinformatics
Institute (EBI), UK] discussed the Global Open
Biology Ontologies (GOBO) effort, which aims to
apply the community-based approach used by GO
to other areas of biology (http://www.geneonto-
logy.org/doc/gobo.html). Key requirements for
inclusion in GOBO are that the ontology be
freely available, and available in a standard for-
mat. One subject area in which the GO commu-
nity is directly involved is that of nucleic acid
sequence types, as described in Suzanna Lewis’s
(University of California at Berkeley, USA) talk
on the Sequence Ontology (SO) project. The SO
categorizes sequence features along three orthog-
onal axes: an ‘is-a’ hierarchy of classes and sub-
classes (e.g. transcript is a subclass of RNA, which
in turn is a subclass of nucleic acid); a classi-
fication based on location (‘is-on’; e.g. an exon
is located on a transcript); and a classification
based on ‘defines’ (e.g. a transcript region defines
a primary transcript). Representatives from model
organism databases, and the EnsEMBL and DAS
(distributed annotation system) projects contribute
to the SO effort.
Alexa McCray (National Library of Medicine,
USA) described the National Library of Medicine’s
Unified Medical Language System (UMLS), which
integrates the contents of about 60 different source
vocabularies into common concepts. The integra-
tion algorithms are available from UMLS website
(http://www.nlm.nih.gov/research/umls/), and it
is clear that the UMLS offers a unique view on
ontologies for biology gained from the mapping
process. In a related talk, Jane Lomax (EBI, UK)
talked about issues encountered when integrating
the GO vocabularies into UMLS, e.g. GO terms
have synonyms, which fall into two distinct classes,
true synonyms and related terms. This distinction
means that merging with UMLS, a system that has
many precisely defined relationships, will mean a
re-evaluation of which synonyms are defined in the
GO. Thus, inclusion of an ontology in UMLS can
drive the development of that ontology.
The session on Ontologies for Model Organ-
isms covered a wide taxonomic range, begin-
ning with two talks on the laboratory mouse. In
the first presentation, Martin Ringwald (Jack-
son Laboratory, USA) described ontologies in
use in the databases provided by the Mouse
Genome Informatics collaboration, emphasizing
the combination of anatomy terms with qual-
ifiers to generate phenotype descriptors. Dun-
can Davidson (MRC Human Genetics Unit,
UK) then demonstrated the Mouse Atlas, in
which links are made between text entries in
an anatomy ontology and three-dimensional mod-
els (http://genex.hgu.mrc.ac.uk/). This approach
facilitates the modelling of gene expression in
three-dimensional space and over time during
development. These models provide a unique and
beautiful view on development of mouse tissues.
Leszek Vincent (University of Missouri, Colu-
mbia, USA) presented the work of the Plant
Ontology Consortium (POC), echoing the theme
of community-based ontology development. The
POC aims to provide ontologies with grounding in
phylogenetics, using structures (anatomy plus mor-
phology) in Zea mays as an initial test case. Sue
Rhee (Carnegie Institution of Washington, USA)
described several ontologies developed by the Ara-
bidopsis Information Resource (TAIR), covering
anatomy, developmental stages and phenotypes,
and used in literature-based database curation
(http://www.arabidopsis.org/info/ontologies/).
The model organism session also encompassed the
nematode C. elegans [3], the fruit fly Drosophila
(Huaiyu Mi), and fungi (Gregory Butler).
The Implementation and Use of Ontologies
session focused on how ontologies can be used
within microarray databases [5] and in indus-
trial settings. Bo Servenius (AstraZeneca, Swe-
den) described a joint project with Spotfire (ven-
dors of microarray analysis software), in which
AstraZeneca contributed annotation and definitions
to the GO project and then incorporated these into
the tools they use locally for microarray analysis.
In another industry perspective, Robin McEntire
[GlaxoSmithKline (GSK), USA] outlined GSK’s
approach to incorporating the efforts in ontology
and standards development into their drug discov-
ery pipelines. Robin emphasized the need for GSK
to use public efforts and their willingness to con-
tribute to them by unveiling a tissue type ontology,
constructed in-house, which they intend to make
public. In the same session, Christian Blaschke
(Universidad Autonoma Madrid, Spain) gave an
NLP perspective on the ontology world in a talk
which described a method for mining terms from
the literature, and applying these to classify poorly
described gene products. This use of the data in
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the literature to generate structured knowledge was
confirmed by use of the GO, which largely verified
the results of the text mining.
Diane Oliver (Stanford University, USA) pre-
sented a knowledge base constructed for repre-
senting SNP data in the context of clinical out-
comes after drug treatment. She provided exam-
ples of known SNPs that can affect patient sur-
vival in combination with drug treatment, and
showed how three ontologies have been imported
into a common environment created using the
Prote´ge´ tool. This knowledge base is now being
used to generate forms through which clinicians
can submit clinical data, and represents a use of
ontologies and knowledge representation that has a
direct health care benefit. Prote´ge´ was described
in detail by Mark Musen (Stanford Univer-
sity, USA) in the session Tools for Building
Ontologies. Prote´ge´ — in a familiar theme — is
a tool that is under development by the commu-
nity that use it, and Musen described a number of
plug-ins that are available from the Prote´ge´ web-
site (http://protege.stanford.edu/). Sean Bech-
hofer (University of Manchester, UK) comple-
mented the description of Prote´ge´ with an expla-
nation of how the standard format DAML +
OIL evolved into OWL, a format also used by
Prote´ge´, and explained how OilEd, an ontology
editor, works.
In the Ontologies for Chemistry, Toxicology
and Other Domains session, both Andrew Jones
(University of Glasgow, UK) and Steve Oliver
(University of Manchester, UK) gave presenta-
tions on the need for proteomics standards. Steve
Oliver introduced PEDRo, an initiative that pro-
vides a database model for proteomics data based
on the maxD system of the University of Manch-
ester, while Andrew Jones presented a modifi-
cation of the microarray community data model
for proteomics experiments. Interestingly, these
approaches are complementary, and the meeting
provided a forum for those interested in developing
standards specifically for proteomics.
Chris Catton (Oxford University, UK) pre-
sented the BioImage project (http://www.bio-
image.org/), highlighting the need for image
archiving and illustrating the challenges involved in
describing images. While image and video formats
are relatively controlled, the subjects of the images
can be interpreted in many ways. He provided an
interesting example of how interpretation and meta-
data affect image interpretation: at first glance, an
image of Jackie Kennedy wearing a leopard-skin
coat looks like a simple news story, but it started
a fashion which had a dramatic impact on the wild
population of the animal in question.
This session was started with an introduction
to the field of chemical ontologies. Tony Davies
(IUPAC, Germany) provided a review of the
structure of IUPAC and outlined the formal way in
which they work to provide unique chemical iden-
tifiers. He was followed by Kirill Degtyarenko
(EBI, UK) on the needs that biochemists have for
specific types of chemical ontologies. The key areas
that he identified were related to structure, enzy-
matic reactions and bioinorganic proteins. He also
noted flaws in the EC system, which limit its use
in describing certain enzyme activities.
Mike Waters (National Institute for Envi-
ronmental Health Sciences, USA) outlined some
of the ways that metadata is gathered in high-
throughput toxicogenomics experiments. To aid
in standardizing this data, standardized pathology
tables are used, and will be included in a devel-
oping knowledge base called CEBS. He also out-
lined the problems in working with the rat, which
has not historically been a genetic model organ-
ism, and described a mapping project in which
emerging rat genomic and EST data are reanno-
tated based on information in the literature. This
resource provides detailed annotation with a toxi-
cogenomic slant, which is currently not available
in public sequence databases.
Conclusions
The importance of involving the research commu-
nity in developing standards and ontologies was
highlighted by many of the speakers; together
with the development and use of open standards
and open source tools, community involvement
emerged as a strong theme throughout the con-
ference. The issue of competing or overlapping
ontologies was also raised in a workshop chaired
by Winston Hide, in which those interested in gene
expression and description of anatomy agreed to
work together to attempt to represent this domain in
a unified way. Readers who are interested in ontol-
ogy developments may wish to look at the GOBO
(http://www.geneontology.org/doc/gobo.html)
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and MGED ontology (http://mged.sourceforge.
net/ontologies/) sites, which list existing ontolo-
gies and tools for ontology development. There are
also discussion lists that run from these sites.
Three of the SOFG speakers have contributed
reviews to this issue of CFG. These were selected
to represent the diversity of ontology development
and to illustrate the use of different ontology-
building tools. Raymond Lee and Paul Sternberg
describe the construction of an ontology to describe
the anatomy and cell lineages of C. elegans [3].
Chris Stoeckert and Helen Parkinson describe the
MGED ontology, which has been developed for
describing microarray experiments [5], and Robert
Stevens et al. provide an introduction to description
logics for beginners, and apply the DL principles
to the Gene Ontology [4].
The abstracts and the presentations from the
meeting are available from http://www.ebi.ac.uk/
SOFG.
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